Determining the Cost-Effectiveness of Mass Screening for Cervical Cancer Using Common Analytic Models | Citedby Results | Acta Cytologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Determining the Cost-Effectiveness of Mass Screening for Cervical Cancer Using Common Analytic Models

Acta Cytologica (1999) 43 (6): 1006–1014.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines

Natasha K. Stout
Amy B. Knudsen
Chung Yin Kong
Pamela M. McMahon
G. Scott Gazelle

PharmacoEconomics (2009) 27 (7): 533.

Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan

Shizuko Nagata-Kobayashi
Takuro Shimbo
Kunihiko Matsui
Tsuguya Fukui

International Journal of Cardiology (2005) 104 (2): 213.

Cost-effectiveness analyses in gynecologic oncology: methodological quality and trends

Michael R Manuel
Lee-may Chen
Aaron B Caughey
Leslee L Subak

Gynecologic Oncology (2004) 93 (1): 1.

The Cost-Effectiveness of Screening Programs Using Single and Multiple Birth Cohort Simulations: A Comparison Using a Model of Cervical Cancer

Sarah Dewilde
Rob Anderson

Medical Decision Making (2004) 24 (5): 486.

Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women

Dulce M Hernández-Hernández
Laura Ornelas-Bernal
Miriam Guido-Jiménez
Teresa Apresa-Garcia
Isabel Alvarado-Cabrero
Mauricio Salcedo-Vargas
Alejandro Mohar-Betancourt
Alejandro Garcia-Carranca

Gynecologic Oncology (2003) 90 (2): 310.

A proposal for cervical screening information systems in developing countries

Loraine D. Marrett
Sylvia Robles
Fredrick D. Ashbury
Bo Green
Vivek Goel
Silvana Luciani

International Journal of Cancer (2002) 102 (3): 293.